Novartis CEO Vasant Narasimhan: The right story for the company was to focus on R&D

Novartis CEO Vasant Narasimhan joins 'Money Movers' to discuss the company's overall M&A strategy, the businesses that Narasimhan wanted to get out of, and how big the Entresto drug can be.